Nanoanalytics

Nanoanalytics

Münster, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Nanoanalytics operates a dual business model combining a DAkkS-accredited analytical service laboratory with an instrument development and manufacturing arm. Its core expertise lies in surface and interface analysis at the nanoscale, serving clients in R&D, quality assurance, and production troubleshooting. The company's flagship products are the cellZscope® systems for real-time, non-invasive TEER measurement, positioning it in the cell biology and barrier function research markets. With over two decades of operation, it has established a reputation for technical expertise, fast turnaround services, and specialized instrumentation.

DiagnosticsProteomics

Technology Platform

Expertise in surface/interface micro-analysis (SEM/EDX, XPS, AFM, ToF-SIMS) and development of instruments for real-time, non-invasive Transepithelial/Transendothelial Electrical Resistance (TEER) measurement under physiological conditions.

Opportunities

Growing demand for advanced, physiologically relevant cell-based assays in drug discovery and basic research presents an opportunity for the specialized cellZscope® system.
Expanding the ecosystem with consumables like cellQART inserts creates a recurring revenue stream.
The constant need for nanoscale failure analysis and quality control in advanced manufacturing provides a stable market for the accredited service laboratory.

Risk Factors

Competition from larger, well-capitalized life science tool companies in the TEER instrumentation space.
Risk of technological obsolescence requiring continuous R&D investment in both service lab equipment and product development.
Vulnerability to reductions in industrial and academic R&D budgets, which are primary sources of demand for both services and instruments.

Competitive Landscape

In analytical services, Nanoanalytics competes with other contract labs and in-house corporate facilities. Its accreditation is a key differentiator. In instruments, it competes with other TEER system providers (e.g., World Precision Instruments, Applied BioPhysics) and generic electrode manufacturers. Its focus on continuous, incubator-based monitoring and specialized consumables defines its niche against broader competitors.